BACKGROUND: 
In hydrocephalus an imbalance 
between production and absorption of cerebrospinal fluid (CSF) results 
in fluid accumulation, compression and stretching of the brain 
parenchyma. In addition, changes in CSF composition have a profound 
influence on the development and function of the brain and together, 
these can result in severe life-long neurological deficits. Brain damage
 or degenerative conditions can result in release of proteins expressed 
predominantly in neurons, astroglia, or oligodendroglia into the brain 
interstitial fluid, CSF and blood. Determination of such products in the
 CSF might be of value in diagnosing cause, aetiology and/or assessing 
the severity of the neurological damage in patients with hydrocephalus. 
We therefore analysed CSF from human neonates with hydrocephalus for 
these proteins to provide an insight into the pathophysiology associated
 with different aetiologies.
METHODS: 
CSF was collected 
during routine lumbar puncture or ventricular tap. Samples were 
categorized according to age of onset of hydrocephalus and presumed 
cause (fetal-onset, late-onset, post-haemorrhagic or spina bifida
 with hydrocephalus). Glial fibrillary acidic protein (GFAP), myelin 
basic protein (MBP), vimentin and 2[prime], 3[prime]-cyclic nucleotide 
3[prime]-phosphodiesterase (CNPase) were analysed through Western 
blotting of hydrocephalic CSF samples (n = 17) and compared with data 
from CSF of normal infants without neurological deficits (n = 8).
RESULTS: 
GFAP
 was significantly raised only in CSF from post-haemorrhagic 
hydrocephalus while MBP was significantly raised in post-haemorrhagic 
and in spina bifida
 with hydrocephalus infants. Vimentin protein was only detected in some 
CSF samples from infants with late-onset hydrocephalus but not from 
other conditions. Surprisingly, CNPase was found in all neonatal CSF 
samples, including normal and hydrocephalic groups, although it was 
reduced in infants with late onset hydrocephalus compared with normal 
and other hydrocephalic groups.
CONCLUSIONS: 
Apart from 
CNPase, which is an enzyme, the markers investigated are intracellular 
intermediate filaments and would be present in CSF only if the cells are
 compromised and the proteins released. Raised GFAP observed in 
post-haemorrhagic hydrocephalus must reflect damage to astrocytes and 
ependyma. Raised MBP in post-haemorrhagic and spina bifida
 with hydrocephalus indicates damage to oligodendrocytes and myelin. 
Vimentin protein detected in some of the late-onset hydrocephalic 
samples indicates damage to glial and other progenitors and suggests 
this condition affects periventricular regions. The presence of CNPase 
in all CSF samples was unexpected and indicates a possible novel role 
for this enzyme in brain development/myelination. Less CNPase in some 
cases of late-onset hydrocephalus could therefore indicate changes in 
myelination in these infants. This study demonstrates differential glial
 damage and loss in the developing human neonatal hydrocephalic brain 
associated with different aetiologies.
 
 
 
No comments:
Post a Comment